发明名称 |
A3 adenosine receptor agonists |
摘要 |
The present invention provides N6-benzyladenosine-5'-N-uronamide and related substituted compounds, particularly those containing substituents on the benzyl and/or uronamide groups, and modified xanthine ribosides, as well as pharmaceutical compositions containing such compounds. The present invention also provides a method of selectively activating an A3 adenosine receptor in a mammal, which method comprises acutely or chronically administering to a mammal in need of selective activation of its A3 adenosine receptor a therapeutically effective amount of a compound which binds with the A3 receptor so as to stimulate an A3 receptor-dependent response. |
申请公布号 |
AU7331094(A) |
申请公布日期 |
1995.02.13 |
申请号 |
AU19940073310 |
申请日期 |
1994.07.13 |
申请人 |
THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, |
发明人 |
KENNETH A. JACOBSON;CAROLA GALLO-RODRIGUEZ;PHILIP J. M VAN GALEN;DAG K. J. E VON LUBITZ;HEAOK KIM JEONG |
分类号 |
C07H19/16 |
主分类号 |
C07H19/16 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|